finance

EU agencies endorse mix-and-match of COVID-19 vaccines



© Reuters. FILE PHOTO: Vials labelled “AstraZeneca, Pfizer – Biontech, Johnson&Johnson, Sputnik V coronavirus disease (COVID-19) vaccine” are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic/Illustration

By Pushkala Aripaka

(Reuters) – EU health agencies have recommended that COVID-19 vaccines be mixed and matched for both initial courses and booster doses as the region battles rising cases ahead of Christmas.

Evidence suggests that the combination of viral vector vaccines and mRNA vaccines produces good levels of antibodies against the coronavirus causing COVID-19, the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) said in a joint statement on Tuesday.

Such an approach “may offer flexibility in terms of vaccination options, particularly to reduce the impact on the vaccine rollout should a vaccine not be available for any reason”, the EMA and ECDC said, while urging people to get fully vaccinated.

Their endorsement comes after a major study on Monday said a first dose of AstraZeneca (NASDAQ:) or Pfizer-BioNTech shots followed by a Moderna (NASDAQ:) vaccine nine weeks later induced a better immune response.

However, the EMA and ECDC said more research was needed to support the use of mixing and matching in people with weak immune systems, such as older people and those with chronic conditions like cancer, and for two-dose mRNA vaccine regimens.

Longevity of protection offered by vaccines has been under scrutiny and the world is scrambling to trace the Omicron variant as governments impose fresh restrictions, and speed up rollouts of vaccines to children and booster doses.

Official rollout of vaccines for 5-11 year olds will start next week in Europe.

The EMA and ECDC recommendations are also meant to help EU member states with their own vaccination campaigns before any formal EU-wide approval as the health agencies continue studying data on mixing vaccines.

The United States has given the green light to mix and match, while the World Health Organization is assessing the approach.

The EMA and ECDC’s review did not consider vaccines that are not approved in the European Union. COVID-19 shots from AstraZeneca, Pfizer-BioNTech, Moderna and Johnson & Johnson (NYSE:) have been authorised for use in the region.

Many countries have deployed a mix and match well before robust data was available as nations faced soaring infection numbers, low supplies and slow immunisation over some safety concerns.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more